FIELD: medicine.
SUBSTANCE: pre-hospital stage involves patient's questionnaire survey and data specification: age in years, patient's height in cm, patient's weight in kg, length of the menstrual cycle if any, in days: in perimenopause or postmenopause, the number of pregnancies in the past medical history in absolute numbers, the number of therapeutic abortions in absolute numbers, administration of oral contraceptives in the past medical history, prevailing protein nutrition, hormone-dependent tumour. The derived values are introduced into formula. The calculated value is used to consider the tumour hormone-dependent, and the patient is given a hormone therapy until the immunohistochemical findings are obtained and a molecular type of breast cancer is specified; otherwise, the tumour is considered to be hormone-independent, so the hormone therapy is not conducted.
EFFECT: by analysing the medical history data and anthropometric measures with the use of the predictive evaluation model of the hormone-dependent tumour in the patients suffering breast cancer, the method enables specifying the indications for the hormone therapy.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING EFFICIENCY OF CHEMOTHERAPY IN TREATMENT OF MAMMARY GLAND CANCER | 2014 |
|
RU2551232C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING DISTANT METASTASES IN PATIENTS WITH OPERABLE FORMS OF BREAST CANCER WITH METASTASES IN REGIONAL LYMPH NODES | 2020 |
|
RU2733697C1 |
METHOD FOR PREDICTION OF HORMONE DEPENDENCE OF BREAST CANCER IN PRIMARY MENOPAUSAL PATIENTS | 2014 |
|
RU2562538C2 |
METHOD FOR PREDICTION OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH THREE-TIMES NEGATIVE MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2623118C1 |
METHOD FOR PREDICTING THE COURSE OF A PATHOLOGICAL PROCESS IN LUMINAL NON-HYPEREXPRESSION OF Her2Neu PRIMARY OPERABLE BREAST CANCER IN POSTMENOPAUSAL WOMEN | 2018 |
|
RU2694843C1 |
METHOD OF PREDICTING HIGH RISK OF REGIONAL METASTASIS IN BREAST CANCER | 2023 |
|
RU2816441C1 |
METHOD FOR PREDICTING HORMONE DEPENDENCE OF MAMMARY GLAND CARCINOMA | 2002 |
|
RU2194992C1 |
METHOD OF PREDICTION OF POSTOPERATIVE COMPLICATIONS OF PATIENT UNDERWENT SURGICAL TREATMENT OF BREAST CANCER | 2017 |
|
RU2683692C1 |
METHOD FOR PREDICTION OF COMPLETE MORPHOLOGICAL REGRESSIONS IN PATIENTS SUFFERING TRIPLE-NEGATIVE RESECTABLE BREAST CANCER | 2014 |
|
RU2560707C1 |
METHOD FOR PREDICTING RISK OF BREAST CANCER PROGRESSION WITH UNDERLYING TAMOXIFEN TAKING INTO ACCOUNT EXPRESSION CHARACTERISTICS OF TUMOUR | 2023 |
|
RU2823488C1 |
Authors
Dates
2015-08-10—Published
2014-09-03—Filed